Garssen MP[Author] - Search Results

Year	Number of Results
1998	1
2002	1
2003	1
2004	2
2006	4
2007	3
2014	1
2020	1
2021	1

1

Guillain-Barré syndrome after SARS-CoV-2 infection.

Kilinc D, van de Pasch S, Doets AY, Jacobs BC, van Vliet J, Garssen MPJ. Kilinc D, et al. Among authors: garssen mpj. Eur J Neurol. 2020 Sep;27(9):1757-1758. doi: 10.1111/ene.14398. Eur J Neurol. 2020. PMID: 32533876 Free PMC article.

2

Physical training and fatigue, fitness, and quality of life in Guillain-Barré syndrome and CIDP.

Garssen MP, Bussmann JB, Schmitz PI, Zandbergen A, Welter TG, Merkies IS, Stam HJ, van Doorn PA. Garssen MP, et al. Neurology. 2004 Dec 28;63(12):2393-5. doi: 10.1212/01.wnl.0000148589.87107.9c. Neurology. 2004. PMID: 15623709 Clinical Trial.

3

Analysing the favourable effects of physical exercise: relationships between physical fitness, fatigue and functioning in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.

Bussmann JB, Garssen MP, van Doorn PA, Stam HJ. Bussmann JB, et al. Among authors: garssen mp. J Rehabil Med. 2007 Mar;39(2):121-5. doi: 10.2340/16501977-0007. J Rehabil Med. 2007. PMID: 17351693 Free article.

4

Treatment of immune neuropathies.

Van Doorn PA, Garssen MP. Van Doorn PA, et al. Among authors: garssen mp. Curr Opin Neurol. 2002 Oct;15(5):623-31. doi: 10.1097/00019052-200210000-00014. Curr Opin Neurol. 2002. PMID: 12352007 Review.

5

Interventions for fatigue in peripheral neuropathy.

White CM, van Doorn PA, Garssen MP, Stockley RC. White CM, et al. Among authors: garssen mp. Cochrane Database Syst Rev. 2014 Dec 18;(12):CD008146. doi: 10.1002/14651858.CD008146.pub2. Cochrane Database Syst Rev. 2014. PMID: 25519471 Review.

6

Screening for anti-ganglioside antibodies in hypocretin-deficient human narcolepsy.

Overeem S, Geleijns K, Garssen MP, Jacobs BC, van Doorn PA, Lammers GJ. Overeem S, et al. Among authors: garssen mp. Neurosci Lett. 2003 Apr 24;341(1):13-6. doi: 10.1016/s0304-3940(03)00085-5. Neurosci Lett. 2003. PMID: 12676332

7

Treatment of Guillain-Barré syndrome with mycophenolate mofetil: a pilot study.

Garssen MP, van Koningsveld R, van Doorn PA, Merkies IS, Scheltens-de Boer M, van Leusden JA, van Schaik IN, Linssen WH, Visscher F, Boon AM, Faber CG, Meulstee J, Prick MJ, van den Berg LH, Franssen H, Hiel JA, van den Bergh PY, Sindic CJ. Garssen MP, et al. J Neurol Neurosurg Psychiatry. 2007 Sep;78(9):1012-3. doi: 10.1136/jnnp.2006.102731. J Neurol Neurosurg Psychiatry. 2007. PMID: 17702789 Free PMC article. Clinical Trial. No abstract available.

8

Residual fatigue is independent of antecedent events and disease severity in Guillain-Barré syndrome.

Garssen MP, Van Koningsveld R, Van Doorn PA. Garssen MP, et al. J Neurol. 2006 Sep;253(9):1143-6. doi: 10.1007/s00415-006-0163-6. Epub 2006 Sep 22. J Neurol. 2006. PMID: 16998652

9

Nerve conduction studies in relation to residual fatigue in Guillain-Barré syndrome.

Garssen MP, van Doorn PA, Visser GH. Garssen MP, et al. J Neurol. 2006 Jul;253(7):851-6. doi: 10.1007/s00415-006-0962-9. Epub 2006 Jul 17. J Neurol. 2006. PMID: 16845568

10

Conduction velocity distribution in neurologically well-recovered but fatigued Guillain-Barré syndrome patients.

Garssen MP, Blok JH, van Doorn PA, Visser GH. Garssen MP, et al. Muscle Nerve. 2006 Feb;33(2):177-82. doi: 10.1002/mus.20451. Muscle Nerve. 2006. PMID: 16270305 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results